BP term |
GO:0030198 |
Extracellular matrix organization |
18 |
2.11E-11 |
BP term |
GO:0030199 |
Collagen fibril organization |
7 |
2.20E-08 |
BP term |
GO:0043200 |
Response to amino acid |
7 |
1.01E-05 |
BP term |
GO:0060840 |
Artery development |
6 |
2.51E-05 |
BP term |
GO:0071230 |
Cellular response to amino acid stimulus |
5 |
4.92E-05 |
CC term |
GO:0098643 |
Banded collagen fibril |
6 |
1.03E-11 |
CC term |
GO:0005583 |
Fibrillar collagen trimer |
6 |
1.03E-11 |
CC term |
GO:0098644 |
Complex of collagen trimers |
6 |
5.86E-10 |
CC term |
GO:0044420 |
Extracellular matrix component |
7 |
2.49E-08 |
CC term |
GO:0031258 |
Lamellipodium membrane |
3 |
2.02E-03 |
MF term |
GO:0030020 |
Extracellular matrix structural constituent conferring tensile strength |
7 |
2.28E-09 |
MF term |
GO:0005539 |
Glycosaminoglycan binding |
13 |
2.09E-08 |
MF term |
GO:0048407 |
Platelet-derived growth factor binding |
4 |
2.68E-07 |
MF term |
GO:0008201 |
Heparin binding |
10 |
4.31E-07 |
MF term |
GO:0019838 |
Growth factor binding |
7 |
4.25E-05 |
KEGG pathway |
hsa04974 |
Protein digestion and absorption |
7 |
2.76E-06 |
KEGG pathway |
hsa04512 |
ECM-receptor interaction |
6 |
2.14E-05 |
KEGG pathway |
hsa05146 |
Amoebiasis |
4 |
4.54E-03 |
KEGG pathway |
hsa04933 |
AGE-RAGE signaling pathway in diabetic complications |
4 |
5.25E-03 |
KEGG pathway |
hsa05150 |
Staphylococcus aureus infection |
3 |
1.20E-02 |